Literature DB >> 17266937

Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.

Shu-Qing Wang1, Qi-Shi Du, Kou-Chen Chou.   

Abstract

The spread of highly pathogenic H5N1 influenza virus in many Asian and European countries as well as its drug-resistance have raised serious worldwide concerns. In this paper, the structure-activity relationship between NA (neuraminidase) and its three inhibitors (DANA, zanamivir, and oseltamivir) was investigated. A homology model of H5N1-NA (BAE46950), which is the first reported oseltamivir-resistance virus strain, and the 108 homology-modeled 3D structures of chicken influenza H5N1 NAs downloaded from the website at , formed the molecular structural basis for the drug-resistance study. The multiple sequence and structure alignment for these NAs indicated that 11 functional residues were highly conserved except for AAF02313 with the mutated virus strain. However, the framework residues have remarkable mutations from N9-NA to H5N1-NA, and a few mutated residues were observed in different H5N1-NAs. A partially hydrophobic site S5 (formed by Ala246 and Thr247) in N9-NA is changed to a hydrophilic site (formed by Ala227 and Asn228) in H5N1-NA, while a hydrophilic site S6 (formed by Asn346 and Asn347) in N9-NA was replaced by a hydrophobic site (formed by Ala323 and Tyr324). All these mutations might be the reason for the oseltamivir-resistance by some H5N1 viruses. In order to find the possible drug-resistant H5N1 virus, similarity analysis was performed using the BAE46950 sequence as the benchmark template, and 21 sequences were found from the database of the 108 H5N1 NAs that had over 95% sequence similarity with BAE46950.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266937     DOI: 10.1016/j.bbrc.2006.12.235

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.

Authors:  Ye Wang; Di Wu; Dahai Yu; Zhiyong Wang; Li Tian; Yanyan Wang; Weiwei Han; Xuexun Fang
Journal:  J Mol Model       Date:  2012-01-27       Impact factor: 1.810

2.  Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.

Authors:  S M Fayaz; G K Rajanikant
Journal:  Mol Divers       Date:  2015-07-14       Impact factor: 2.943

3.  Docking and molecular dynamics study on the inhibitory activity of N, N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein.

Authors:  Bo-Liang Dong; Qing-Hua Liao; Jing Wei
Journal:  J Mol Model       Date:  2010-11-06       Impact factor: 1.810

4.  In-silico structural analysis of the influenza A subtype H7N9 neuraminidase and molecular docking with different neuraminidase inhibitors.

Authors:  Ahmad F Eweas; Ahmed S Abdel-Moneim
Journal:  Virusdisease       Date:  2015-02-05

5.  In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir.

Authors:  V Karthick; V Shanthi; R Rajasekaran; K Ramanathan
Journal:  Protoplasma       Date:  2012-03-06       Impact factor: 3.356

Review 6.  Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem.

Authors:  Ge-Fei Hao; Guang-Fu Yang; Chang-Guo Zhan
Journal:  Drug Discov Today       Date:  2012-07-10       Impact factor: 7.851

7.  Computer-aided de novo ligand design and docking/molecular dynamics study of vitamin D receptor agonists.

Authors:  Xiu-Long Shen; Midori Takimoto-Kamimura; Jing Wei; Qing-Zhi Gao
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

8.  Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus.

Authors:  Shih-Jen Lu; Fok-Ching Chong
Journal:  Int J Mol Sci       Date:  2012-04-10       Impact factor: 6.208

9.  Structural origins for the loss of catalytic activities of bifunctional human LTA4H revealed through molecular dynamics simulations.

Authors:  Sundarapandian Thangapandian; Shalini John; Prettina Lazar; Sun Choi; Keun Woo Lee
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.

Authors:  Jiao-Yu He; Cheng Li; Guo Wu
Journal:  Drug Des Devel Ther       Date:  2014-12-01       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.